Andexanet alfa: a recombinant mimetic of human factor Xa for the reversal of anticoagulant therapies.
Sign Up to like & getrecommendations! Published in 2017 at "Drugs of today"
DOI: 10.1358/dot.2017.53.5.2630780
Abstract: Activated coagulation factor X (FXa) is a common target for classic and newer anticoagulants. Parenteral anticoagulants with an indirect inhibitory action on FXa (low-molecular-weight heparins) have a well-established clinical efficacy in the prophylaxis and therapy… read more here.
Keywords: fxa; anticoagulant therapies; reversal anticoagulant; alfa ... See more keywords